Mumbai: Pharmaceutical major Lupin on Thursday said its consolidated net profit for the third quarter (Q3) ended 31 December 2008, declined by 35.58% to Rs116.50 crore.
The company had a net profit of Rs180.86 crore for the same quarter in the last financial year, Lupin said in a filing to the Bombay Stock Exchange.
Total income of the company rose to Rs983.68 crore for the quarter under review, against Rs856.25 crore in the same period last year.
“The past 10 quarters have been noteworthy. We have continued to outpace and outperform across business segments and markets consistently having steadily consolidated our footprint globally,” Lupin managing director Kamal Sharma said.
For the nine months ended 31 December, the company has a net profit of Rs344.16 crore, against Rs312.38 crore in the same period last year.